GM-CSF protects against pneumococcal pneumonia in the lungs by upregulating iNOS expression through PU.1 and STAT5 signals, which contribute to the antibacterial activity of AMs against pneumococcal pneumonia (87). Here, CSF2 is linked to pneumococcal pneumonia.